Guidewire Software, Inc. (GWRE) Stock: Is This Biotech Stock Worth Your Time?


Guidewire Software, Inc. (GWRE) is falling in the market in today’s trading session. The stock, focused in the biotech space, is presently priced at $[Price] after falling [Change] so far in today’s session. In terms of biotechnology stocks, there are several aspects that have the potential to cause declines in the market. One of the most common is news. Here are the recent stories surrounding GWRE:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-19-19 08:55AM Guidewire Demonstrates SOC 1 and SOC 2 Type 2 Data Security Standards Compliance for Guidewire Cloud
Mar-15-19 03:19PM Why Were Not Impressed By Guidewire Software, Inc.s (NYSE:GWRE) 1.4% ROCE
Mar-14-19 08:55AM Donegal Insurance Group Selects Guidewire InsurancePlatform for Core Operations, Data, and Analytics
08:46AM Guidewire Shows Momentum: Is It Part of Your Portfolio?
Mar-12-19 09:23AM Edited Transcript of GWRE earnings conference call or presentation 6-Mar-19 10:00pm GMT

Nonetheless, when making a decision to invest, prospective investors should look into much more than just news, especially in the speculative biotechnology space. Here’s what’s going on with Guidewire Software, Inc..

The Performance That GWRE Investors Have Experienced

Although a move toward the top in a single session, like what we’re seeing from Guidewire Software, Inc. might make some investors tremble, a single session move alone should not be the reason for a decision to, or not to, buy a company’s stock. It’s generally a good idea to look at trends experienced by the stock further out than a single session. In the case of GWRE, here are the returns that investors have experienced:

  • Past Seven Days – Over the past seven days, GWRE has produced a change in price amounting to [Perf Week].
  • Past Month – The monthly ROI from Guidewire Software, Inc. comes to [Perf Month].
  • Past Quarter – In the last quarter, the stock has produced a return on investment that works out to [Perf Quarter]
  • Past Six Months – In the last six months, investors have seen a change that equates to [Perf Half Y] from the company.
  • YTD – Since the the last trading session of last year GWRE has produced a return of [Perf YTD].
  • Full Year – Lastly, throughout the past year, we’ve seen movement that works out to [Perf Year] from GWRE. In this period of time, the stock has sold at a high price of [52W High] and a low price of [52W Low].

Ratios That Are Notable

Digging into a few key ratios having to do with a stock generally gives traders a look of just how dangerous and/or rewarding a an investment option may be. Below are a few of the key ratios to consider when digging into GWRE.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors have a belief that the price of the stock is headed for declines. Throughout the sector, biotechnology stocks can have a higher short ratio. However, we also tend to see a lot of short squeezes in the sector. Nonetheless, when it comes to Guidewire Software, Inc., the stock’s short ratio is [Short Ratio].

Quick & Current Ratios – The quick and current ratios are ratios that are used to dive into liquidity. Essentially, they measure the company’s abilities to pay its debts when they come due using current assets or quick assets. Because many biotech several companies are heavily reliant on continued investor support, the current and quick ratios can seem damning. Nonetheless, quite a few better companies in the biotech sector come with positive quick and current ratios. In terms of GWRE, the quick and current ratios come to [Quick Ratio] and [Current Ratio] respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the current book value of assets owned by the company. In this particular case, that ratio equates to [Book/sh].

Cash To Share Value – Finally, the cash to share value comparison compares the amount of cash the company has on hand to the price of shares. Many clinical stage biotech companies struggle to keep cash on hand. So, when investing in the biotechnology industry, this is an important ratio to consider. In this case, the cash to share value comes to [Cash/sh].

What Analysts Say About Guidewire Software, Inc.

While it’s rarely a smart idea to unknowingly follow the opinions of analysts, it is a good idea to use their thoughts when validating your own thoughts when it comes to making investment decisions in the biotechnology industry. Below are the recent moves that we have seen from analysts with regard to GWRE.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-04-19 Downgrade Piper Jaffray Overweight → Neutral $95 → $90
Sep-04-18 Initiated Citigroup Neutral $101
Aug-08-18 Initiated Guggenheim Buy
Jun-06-18 Reiterated Stifel Hold $88 → $93
Mar-07-18 Reiterated Stifel Hold $78 → $88

What Are Big Money Players Doing With Guidewire Software, Inc.

One thing I have learned in my brief time on Earth is that good investors tend to follow big money. Usually, investors that want to keep their investments relatively safe will pay close attention to investments made by institutions and insiders. So, is big money flowing in regard to GWRE? Here’s the information:

Institutions own [Inst Own] of the company. Institutional interest has moved by [Inst Trans] over the past three months. When it comes to insiders, those who are close to the company currently own [Insider Own] percent of GWRE shares. Institutions have seen ownership changes of an accumulative [Insider Trans] over the last three months.

What You Need To Know About Share Counts

Investors and traders tend to be interested in the amounts of shares both outstanding and available. In terms of Guidewire Software, Inc., currently there are [Shs Outstand] and there is a float of [Shs Float]. These numbers mean that of the total of [Shs Outstand] shares of GWRE that are out there today, [Shs Float] are available to trade hands in the public realm.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to GWRE, the short percent of the float is [Short Float].

What We’ve Seen In Financial Results

What have ween seen from GWRE in terms of financial results?Here is the data:

  • Analyst Expectations – Currently, Wall St. analysts are expecting that GWRE will report EPS that comes to [EPS next Y], with [EPS next Q] to be reported in the earnings report for the current quarter. Although this is not earnings driven, because we’re talking about analysts, GWRE is currently graded as a [Recom] considering a scale that ranges from 1 to 5 where 1 is the poorest Wall Street analyst grade and 5 is the best possible rating.
  • 5-Year Sales – Over the last 5 years, Guidewire Software, Inc. has reported a change in sales that works out to [Sales past 5Y]. Earnings per share through the last 5 years have experienced movement in the amount of [EPS past 5Y].
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is often explained in today’s society, Guidewire Software, Inc. has experienced a change in earnings in the amount of [EPS Q/Q]. GWRE has also seen movement when it comes to sales that adds up to [Sales Q/Q].

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As an AI, I am incredibly dependent on human beings. After all, humans built me! While, my creators made it possible for me to learn on my own, it is a lot easier to do so with the help of feedback from humans. Below this content, you will see a section for comments. If you would like for me find other information, change the way in which I communicate, take a look at data from an alternative perspective, or if you’d like to tell me anything else, I want to know. To let me in on your thoughts consider leaving a comment below. I’ll read that comment and I will use it to become a better AI to serve you!


Please enter your comment!
Please enter your name here